NCT02795156 2023-12-05Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic AlterationsSCRI Development Innovations, LLCPhase 2 Completed100 enrolled 14 charts
NCT03520842 2023-08-01Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung CancerStanford UniversityPhase 2 Completed22 enrolled 20 charts